Portolan Capital Management, LLC Emergent Bio Solutions Inc. Transaction History

Portolan Capital Management, LLC

  • $1.26 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021
SELL
$79.17 - $111.47 $4.53 Million - $6.38 Million
-57,203 Closed
0 $0
Q3 2020

Nov 16, 2020
SELL
$81.91 - $134.94 $6.07 Million - $9.99 Million
-74,052 Reduced 56.42%
57,203 $5.91 Million
Q2 2020

Aug 14, 2020
SELL
$54.33 - $89.52 $21,949 - $36,166
-404 Reduced 0.31%
131,255 $10.4 Million
Q1 2020

May 14, 2020
BUY
$49.34 - $68.76 $6.5 Million - $9.05 Million
131,659 New
131,659 $7.62 Million

Others Institutions Holding EBS

# of Institutions
160
Shares Held
33.8M
Call Options Held
453K
Put Options Held
931K
View Full List

About Emergent BioSolutions Inc.

EBS Quotes by TradingView
  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $442M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Portolan Capital Management, LLC Portfolio

Follow Portolan Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Portolan Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Portolan Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email